Diffuse large B cell lymphoma biopsy: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(16 intermediate revisions by 4 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Diffuse large B cell lymphoma}}
{{Diffuse large B cell lymphoma}}
{{CMG}}
{{CMG}}; {{AE}} {{AS}} {{AHS}}
==Overview==
==Overview==
[Medical diagnosis|Diagnosis]] of Diffuse large B cell lymphoma is made by removing a portion of the tumour through a [[biopsy]], and then examining this tissue using a microscope. Usually an experienced [[Hematopathology|hematopathologist]] makes this diagnosis.
Excisional Lymph node or extranodal tissue biopsy is diagnostic of diffuse large B cell lymphoma.


==Biopsy==
==Biopsy==
[Medical diagnosis|Diagnosis]] of Diffuse large B cell lymphoma is made by removing a portion of the tumour through a [[biopsy]], and then examining this tissue using a microscope. Usually an experienced [[Hematopathology|hematopathologist]] makes this diagnosis.
*Surgical Excision Biopsy of Lymph node or extranodal tissue is diagnostic of diffuse large B cell lymphoma.<ref name="”seer”">National Cancer Institute. Surveillance, Epidemiology, and End Results Program 2015. http://seer.cancer.gov</ref>
 
*Needle-Core Excision and Endoscopic Biopsies should be reserved for patients in which surgery is too risky or impractical.
*FNA not used for diagnosis alone.
*To view findings on biopsy characteristic of each morphological variant of diffuse large B cell lymphoma, click [[Diffuse large B cell lymphoma pathophysiology #Microscopic Pathology|'''here''']].
*morphological Diagnosis of DLBCL on Biopsy should always be confirmed by Immunophenotypic techniques like Flow cytometry or IHC or Both.


==References==
==References==
{{reflist|2}}
{{reflist|2}}


[[Category:Needs content]]
[[Category:Disease]]
[[Category:Disease]]
[[Category:Types of cancer]]
[[Category:Types of cancer]]
Line 18: Line 20:
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Hematology]]
[[Category:Immunology]]

Latest revision as of 03:40, 20 June 2018

Diffuse large B cell lymphoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Diagnosis

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Biopsy

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Diffuse large B cell lymphoma biopsy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Diffuse large B cell lymphoma biopsy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Diffuse large B cell lymphoma biopsy

CDC on Diffuse large B cell lymphoma biopsy

Diffuse large B cell lymphoma biopsy in the news

Blogs on Diffuse large B cell lymphoma biopsy

Directions to Hospitals Treating Diffuse large B cell lymphoma

Risk calculators and risk factors for Diffuse large B cell lymphoma biopsy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2] Anila Hussain, MD [3]

Overview

Excisional Lymph node or extranodal tissue biopsy is diagnostic of diffuse large B cell lymphoma.

Biopsy

  • Surgical Excision Biopsy of Lymph node or extranodal tissue is diagnostic of diffuse large B cell lymphoma.[1]
  • Needle-Core Excision and Endoscopic Biopsies should be reserved for patients in which surgery is too risky or impractical.
  • FNA not used for diagnosis alone.
  • To view findings on biopsy characteristic of each morphological variant of diffuse large B cell lymphoma, click here.
  • morphological Diagnosis of DLBCL on Biopsy should always be confirmed by Immunophenotypic techniques like Flow cytometry or IHC or Both.

References

  1. National Cancer Institute. Surveillance, Epidemiology, and End Results Program 2015. http://seer.cancer.gov


Template:WikiDoc Sources